Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

RXRX

RECURSION PHARMACEUTICALS, INC.

CIK 0001601830 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$3.76
↑ 0.04 (1.08%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Options; Risks: Fundamentals

Key stats

Market Cap
$632.89M
P/E Ratio
-1.13
EPS
-1.44
Dividend Yield
Not covered
52W Position
22%
Beta
2.87

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
0.62
P/S
9.53
EV/Revenue
-0.33
ROE
-54.6%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 22%
$2.77$7.18

Latest Financials

2025-12-31 FY
Revenue
$74.68M
Net Income
-$644.76M
Total Assets
$1.47B
Free Cash Flow
-$378.28M

Recent news